Erlotinib: An enhancer of radiation therapy in nasopharyngeal carcinoma

The aim of this study was to explore the effects of erlotinib combined with radiation on human nasopharyngeal carcinoma (NPC) radiosensitivity using the CNE1 and CNE2 cell lines. Human NPC cells were treated with erlotinib and/or radiation. The effect of erlotinib on the radiosensitivity of the cell...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, HUAN-HUAN, YUAN, TAI-ZE, LI, JIAN, LIANG, YIN, HUANG, LAI-JI, YE, JIA-CAI, ZHENG, RONG-HUI, XIE, GUO-FENG, ZHANG, XIU-PING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797307/
https://www.ncbi.nlm.nih.gov/pubmed/24137317
http://dx.doi.org/10.3892/etm.2013.1245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797307/
https://www.ncbi.nlm.nih.gov/pubmed/24137317
http://dx.doi.org/10.3892/etm.2013.1245

Ejemplares similares